Embed Size (px)
Citation preview
1
Indian Pharma Industry
By Balaji Roy
2
How?
Footer Text 3
How?
Footer Text 4
Generic drug development
5
Pharma Value Chain
6
Indian Pharmaceutical Evolution
Phase II
Government Control•Indian Patent Act –1970•Drug prices capped•Local companies begin to make an impact
Phase III Development Phase
•Process development
•Production infrastructure creation
•Export initiatives
Phase IV
Growth Phase
•Rapid expansion of domestic market
•International market development
•Research orientation
Phase V
Innovation and Research•New IP law•Discovery Research •Convergence
1970 1980 1990 2000 2010
Phase I
Early Years•Market share domination by foreign companies•Relative absence of organized Indian companies
7
India Market• India saw its first pharmaceutical company in 1930,
Bengal Chemicals and Pharmaceuticals works
• Till 1970s Indian pharmaceutical market was non existent
• Indian Pharmaceutical market currently stands at approximately 23.6 bn USD**
• 10500 manufacturing units, 3000 pharma companies*
8
Interesting Facts• Branded generics dominate the retail market with
70-80% share
• Price levels and margins are low due to intense competition
• India ranks 10th globally in terms if value, 3rd in terms of volume
• Last 5 years the growth rate is ranging between 13-14% as compared to 9% before that
04/11/2023Footer Text 9
Growth Drivers
04/11/2023Footer Text 10
Growth Predictions
11
Opportunities• As per 'Pharma Vision 2020', the Government of India aims
to make India a global leader in end-to-end drug manufacturing**
• Manufacturing costs in India are approximately 35-40 per cent of those in the US due to low installation and manufacturing costs**
• The biologics market will grow to 3 bn USD by 2020*
• The projected human resource requirement in the Indian pharma sector is estimated to be about 21,50,000 by 2020**
• Industry Least affected by recession
12
Opportunities Contd.• Due to increasing population and income levels, demand for
high-end drugs is expected to reach US$ 8 billion by 2015
• Expenditure on pharmaceuticals is likely to increase to over 40 per cent of the total spending on healthcare by households by 2015 from 28 per cent in 2007
• With 70 per cent of India's population residing in rural markets, various pharma companies are investing in the distribution network in rural areas
• Increased penetration of chemists, especially in the rural parts of the country would make OTC drugs easily available
13
Current Top Players - India
14
US Contribution
15
US Generics Market share
16
Indian impact in US
17
Indian Pharma in Speciality products
18
ANDA pipeline
04/11/2023Footer Text 19
US Acquisitions
20
USFDA Issues
21
Country wise Import alerts
22
Factor wise comparison
23
Factor wise comparison
24
Factor wise comparison
25
Thank You!
